Phorbol Ester Abrogates Up-regulation of DNA Polymerase by DNA-alkylating Agents in Chinese Hamster Ovary Cells

Mammalian DNA polymerase β (β-pol), a DNA repair polymerase, is known to be constitutively expressed in cultured cells, but treatment of cells with the DNA-alkylating agents MNNG or methyl methanesulfonate has been shown to up-regulate β-pol mRNA level. To further characterize this response, we p...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of biological chemistry Vol. 270; no. 27; p. 16402
Main Authors Deepak K. Srivastava, Teresa Y. Rawson, Stephen D. Showalter, Samuel H. Wilson
Format Journal Article
LanguageEnglish
Published American Society for Biochemistry and Molecular Biology 07.07.1995
Online AccessGet full text

Cover

Loading…
More Information
Summary:Mammalian DNA polymerase β (β-pol), a DNA repair polymerase, is known to be constitutively expressed in cultured cells, but treatment of cells with the DNA-alkylating agents MNNG or methyl methanesulfonate has been shown to up-regulate β-pol mRNA level. To further characterize this response, we prepared a panel of monoclonal antibodies and used one of them to quantify β-pol in whole cell extracts by immunoblotting. We found that treatment of Chinese hamster ovary cells with either DNA-alkylating agent up-regulated the β-pol protein level 5-10-fold. This induction appeared to be secondary to DNA alkylation, as induction was not observed with a genetically altered cell line overexpressing the DNA repair enzyme O 6 -methylguanine-methyltransferase. We also found that 12- O -tetradecanoylphorbol-13-acetate (TPA) treatment of wild type Chinese hamster ovary cells increased expression of β-pol protein ( 10-fold). Any interrelationship between this TPA response and the DNA-alkylation response was studied by treatment with combinations of MNNG and TPA. The β-pol up-regulation observed with MNNG treatment was abrogated by TPA, and conversely the up-regulation observed with TPA treatment was abrogated by MNNG.
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.270.27.16402